An interventional study of Strengthening COnnections to Overcome Pain (SCOOP) in Chronic Pain, sponsored by Weill Medical College of Cornell University. Recruiting at 1 site in United States. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-08-05.
Sponsored by Weill Medical College of Cornell University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Chronic Pain by Weill Medical College of Cornell University — 5 open to participants now, 6 under way, none of them phase 3. Chronic Pain · Weill Medical College of Cornell University.
Among the 18 studies in Chronic Pain by Weill Medical College of Cornell University, this one is the 10th largest by planned enrollment of the 15 interventional ones that give a count, is the only one that started in 2026, is one of 13 with no phase, and was the 16th registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →5 of the 18 studies in Chronic Pain by Weill Medical College of Cornell University are open now, in 1 country. Recruiting first, the newest first:
Weill Medical College of Cornell University · Sites in United States
Ages 18+
Weill Medical College of Cornell University · Sites in United States
Ages 18+
Weill Medical College of Cornell University · Sites in United States
Ages 21+
Weill Medical College of Cornell University · Sites in United States
Ages 18+ · Healthy volunteers
By country, each count listing its studies:
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 60 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is above the median of 60 across 2,388 interventional studies indexed under Chronic Pain.
Median enrollment 95 across the 15 interventional studies, 55 across the 3 observational. Of the 11 that completed or were terminated, 5 (45%) have results posted.
This tab as a report to print or save as PDF → With an account.
Weill Medical College of Cornell University is the lead sponsor of 893 studies on the registry; 165 are open to participants now.
Of its 124 completed or terminated interventional studies of FDA-regulated products, 95 (77%) have results posted.
4 of the studies in Chronic Pain by Weill Medical College of Cornell University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06671925Weill Medical College of Cornell UniversityA Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults | 2027-05-31 |
| NCT07225049Weill Medical College of Cornell UniversityIntegrated PTSD and Chronic Pain Treatment | 2027-08 |
| NCT06800209Weill Medical College of Cornell UniversityPain Reprocessing Therapy in Post-Operative Knee Pain | 2027-09-30 |
| NCT06168604Weill Medical College of Cornell UniversityEvaluating the Efficacy of the Pain Identification and Communication Toolkit | 2027-10-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 18 studies in Chronic Pain by Weill Medical College of Cornell University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to test a new community health worker-delivered program (Strengthening COnnections to Overcome Pain, or SCOOP) that teaches strategies for managing chronic pain and loneliness to older adults living in rural areas. The main questions it aims to answer are:
Participants will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
SCOOP is a 7-week intervention, delivered primarily over the telephone by community health workers, to support chronic pain self-management and social connectedness.
Behavioral: Strengthening COnnections to Overcome Pain (SCOOP)
Control group participants receive usual care between the baseline and 8-week follow-up survey. After completing the follow-up survey, control participants will be invited to take part in an educational workshop about pain and loneliness and will receive all intervention materials.
Each week for 7 weeks, SCOOP intervention group participants will watch a brief video on the study website teaching a pain management or social connectedness skill and have a session with a community health worker, where they will receive support with behavioral goal-setting related to pain management and/or social connections. Participants will be screened for unmet social needs and connected to appropriate resources.
Engagement as measured by number of sessions completed
Number of sessions out of 7 that participants have completed 8 weeks from baseline.
Time frame: 8 weeks from baseline
Participant satisfaction with the SCOOP intervention
Items ask about overall satisfaction with the program, i.e., whether participation increased understanding of pain management and increased knowledge of strategies to improve social connection (1= Strongly Disagree to 5= Strongly Agree). The mean of the two items will be calculated. A higher score indicates greater participant satisfaction with the intervention.
Time frame: 8 weeks from baseline
Change in Loneliness as measured by the UCLA 8-item Loneliness Scale
Eight items ask about feelings of loneliness and social isolation. Each question is rated on a 4-point scale: 1=never, 2=rarely, 3=sometimes, and 4 =always. Two positively worded items ("I am an outgoing person" and "I can find companionship when I want it" are reverse-scored. All items are summed to give a total score of 8 to 32 points. A higher score indicates a greater degree of loneliness.
Time frame: Baseline, 8 weeks from baseline
Change in Pain Interference 6-item subscale from PROMIS-43 Adult Profile
Items ask how much pain in the last 7 days has interfered with daily activities such as household chores and social activities (1=not at all to 5=very much); raw total scale scores range from 6 (low interference) to 30 (high interference). Scores are converted to a standardized T-score metric, with a mean of 50 and a standard deviation of 10 in a referent population. A higher score means more of the concept being measured.
Time frame: Baseline, 8 weeks from baseline
Global Impression of Change in Pain, Functioning, and Loneliness
Three items, analyzed separately: 1) How participant thinks their pain has changed from baseline (much worse (-3) to much better(+3)). 2) How participant thinks their functioning has changed from baseline (much worse (-3) to much better(+3)). 3) How participant thinks their feelings of loneliness have changed from baseline (much worse (-3) to much better(+3)).
Time frame: 8 weeks from baseline
Started Jan 2026 (actual). Primary completion is estimated for May 2027, 16 months after the start.
Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 16 months is below that.
Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Weill Medical College of Cornell University →